GOLM1 and hepatocellular carcinoma: A study from Jiang et al showed that patients with high GP73 expression achieved poorer outcome than those with low or no GP73 expression in hepatocellular carcinoma (HCC) [17], however, Sun et al’s reports showed no survival difference between both groups in terms of GP73 expression [18].